Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19402
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKatritsis, D. G.en
dc.contributor.authorIoannidis, J. P.en
dc.date.accessioned2015-11-24T18:59:44Z-
dc.date.available2015-11-24T18:59:44Z-
dc.identifier.issn1524-4539-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19402-
dc.rightsDefault Licence-
dc.subjectAngina Pectoris/therapyen
dc.subject*Angioplasty, Balloon, Coronary/adverse effects/statistics & numerical dataen
dc.subjectBayes Theoremen
dc.subjectCardiovascular Agents/therapeutic useen
dc.subjectCoronary Artery Disease/therapyen
dc.subjectCoronary Disease/drug therapy/surgery/*therapyen
dc.subjectCoronary Stenosis/therapyen
dc.subjectDeathen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectMyocardial Infarctionen
dc.subjectMyocardial Revascularizationen
dc.subjectOdds Ratioen
dc.subjectRandomized Controlled Trials as Topicen
dc.subjectRisk Assessmenten
dc.subjectTreatment Outcomeen
dc.titlePercutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysisen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1161/CIRCULATIONAHA.104.521864-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/15927966-
heal.identifier.secondaryhttp://circ.ahajournals.org/content/111/22/2906.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2005-
heal.abstractBACKGROUND: Percutaneous coronary intervention (PCI) has been shown to improve symptoms compared with conservative medical treatment in patients with stable coronary artery disease (CAD); however, there is limited evidence on the effect of PCI on the risk of death, myocardial infarction, and subsequent revascularization. Therefore, we performed a meta-analysis of 11 randomized trials comparing PCI to conservative treatment in patients with stable CAD. METHODS AND RESULTS: A total of 2950 patients were included in the meta-analysis (1476 received PCI, and 1474 received conservative treatment). There was no significant difference between the 2 treatment strategies with regard to mortality, cardiac death or myocardial infarction, nonfatal myocardial infarction, CABG, or PCI during follow-up. By random effects, the risk ratios (95% CIs) for the PCI versus conservative treatment arms were 0.94 (0.72 to 1.24), 1.17 (0.88 to 1.57), 1.28 (0.94 to 1.75), 1.03 (0.80 to 1.33), and 1.23 (0.80 to 1.90) for these 5 outcomes, respectively. A possible survival benefit was seen for PCI only in trials of patients who had a relatively recent myocardial infarction (risk ratio 0.40, 95% CI 0.17 to 0.95). Except for PCI during follow-up, there was no significant between-study heterogeneity for any outcome. CONCLUSIONS: In patients with chronic stable CAD, in the absence of a recent myocardial infarction, PCI does not offer any benefit in terms of death, myocardial infarction, or the need for subsequent revascularization compared with conservative medical treatment.en
heal.journalNameCirculationen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Katritsis-2005-Percutaneous coronar.pdf340.45 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons